Nanovaccines: An effective therapeutic approach for cancer therapy
2023 · Biomedicine & Pharmacotherapy · 65 citations
https://doi.org/10.1016/j.biopha.2023.115992
L
Lin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
242
Papers
2.9K
Citations
32
h-index
76
i10-index
Lin Wang is an academic researcher from Institute on Aging. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & HER2/EGFR in Cancer Research & RNA modifications and cancer. The author has an h-index of 32, co-authored 206 publications.
ORCID: 0000-0003-2433-8594Papers by this author
worksMeta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
2019 · Annals of Hepatology · 59 citations
https://doi.org/10.1016/j.aohep.2019.11.008
Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer
2021 · Scientific Reports · 57 citations
https://doi.org/10.1038/s41598-021-82976-w
The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China
2021 · Technology in Cancer Research & Treatment · 17 citations
https://doi.org/10.1177/15330338211037812
Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
2009 · Journal of Huazhong University of Science and Technology [Medical Sciences] · 7 citations
https://doi.org/10.1007/s11596-009-0318-7
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
2024 · Global Medical Genetics · 6 citations
https://doi.org/10.1055/s-0044-1790230
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat